Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.0.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:17:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Location entry updated from Napoli, Italy, 80123 to Naples, Italy, 80123. Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:20:10.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    New registry identifiers UTN and EU CT were added and old registry references updated. The page now includes links for trial transparency data sharing (trialstransparency PDF) and external data sharing site.
    Difference
    0.3%
    Check dated 2026-02-20T17:14:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:51:53.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Minor update: the page now displays Revision: v3.4.1 and removes Revision: v3.4.0, indicating a small version bump. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.